Lose Up to 14%+ of Your Body Weight With the Wegovy® Pill — No Needles Required

Prescription products require an online evaluation with a licensed medical professional who will determine if a prescription is appropriate. See important safety information. Benefits outlined on Get Thin MD are based on 3rd party studies. Medications are prescribed by licensed physicians as part of our weight loss programs. Actual product packaging may appear differently than shown. Physicians may prescribe compounded medications as needed to meet patient requirements or drug shortages. The FDA does not review or approve any compounded medications for safety or effectiveness.

Should you seek a prescription item, Get Thin MD will facilitate arranging a consultation with a qualified Healthcare Provider. The Provider will assess your suitability for the prescription item. If deemed suitable, a doctor may issue a prescription for the item, which can be filled at a partner pharmacy, unless you specify an alternative preference.

As part of our efforts to ensure patient safety, we need to verify your phone number. By giving us your phone number and continuing, you agree that Get Thin MD  may send text messages to you to verify your phone number and for any other lawful purpose related to your Get Thin MD account and your use of our services, including order confirmations, shipment notifications, and messages from your provider. Message and data rates may apply. Message frequency varies. Additionally, by providing your phone number, you agree to receive marketing emails and other promotional communications from Get Thin MD. You also consent to Get Thin MD using your information for third-party advertising purposes, including but not limited to targeted advertising on platforms such as Facebook, Google, and other similar sites. This includes using hashed and de-identified data to create custom audiences for targeted advertising and to exclude existing customers from certain marketing campaigns. You can opt-out of receiving marketing emails at any time by following the unsubscribe instructions provided in each email or by contacting us directly at support@getthinusa.com.
‍
Note: The above statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
The FDA does not review. compounded medications for safety or efficacy. GetThinMD does not manufacture or dispense medications. GetThinMD connects patients with licensed healthcare providers who may prescribe treatments based on individual eligibility. This product is available by prescription only. Individual results may vary. Bottle used for visual purposes only. Safety information may be found at https://www.getthinusa.com/important-safety-information

¹ Wegovy® (semaglutide) is a prescription medication manufactured by Novo Nordisk. The Wegovy® Pill (oral semaglutide 25 mg) was approved by the U.S. Food and Drug Administration on December 22, 2025 as the first and only oral GLP-1 receptor agonist indicated for chronic weight management in adults with obesity, or adults with overweight who have at least one weight-related medical condition. Get Thin MD is an independent telehealth platform and is not affiliated with, endorsed by, or sponsored by Novo Nordisk. Wegovy® is a registered trademark of Novo Nordisk A/S. https://www.prnewswire.com/news-releases/fda-approves-novo-nordisks-wegovy-pill-the-first-and-only-oral-glp-1-for-weight-loss-in-adults-302648344.html

² OASIS 4 Trial — 13.6% mean weight loss (treatment-policy analysis); 16.6% with full adherence https://www.novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=916472

³ "28% of adults lost 20%+ body weight vs 3% on placebo" — Wegovy.com OASIS 4 results page https://www.wegovy.com/obesity/is-wegovy-right-for-me/wegovy-pill-results.html(This is the official Novo Nordisk patient-facing page citing the exact 28% / 3% / 235 lb / 231 lb figures. This is the ideal source to link since the language matches your copy verbatim.)

⁴ Wegovy® Pill (oral semaglutide) tablets are FDA-approved and supplied by Novo Nordisk in dosage strengths of 1.5 mg, 4 mg, 9 mg, and 25 mg. Dosing is determined by a licensed medical provider based on the patient's individual health profile, treatment response, and tolerability. Not all dosages may be appropriate for every patient.https://www.endocrinologyadvisor.com/news/fda-approves-oral-wegovy-for-weight-management/